Physician profile
Aditya Joshi
NPI 1093160202
$2,282.72
in general payments reported to CMS, 2019-2025
15 companies · $79.39 in 2025
The $79.39 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $347 · 2021: $916 · 2022: $517 · 2023: $41.01 · 2025: $79.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $120.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $778.96 | 2019-2023 | Cardiomems |
| Astellas Pharma US INC | $438.17 | 2019-2022 | |
| Boston Scientific Corporation | $222.91 | 2020-2021 | |
| Novo Nordisk INC | $125.00 | 2022 | |
| Cardiovascular Systems INC. | $116.38 | 2021 | |
| Terumo Medical Corporation | $100.00 | 2022 | |
| Abiomed | $79.39 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $78.26 | 2019 | |
| Amgen INC. | $69.77 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.48 | 2020-2021 | |
| Esperion Therapeutics, INC. | $56.77 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $47.76 | 2019-2021 | |
| Medtronic, INC. | $35.62 | 2021 | |
| Biotronik INC. | $35.27 | 2021 | |
| Pfizer INC. | $28.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aditya Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.